-
Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
-
Roshni D. Kalachand, Ciaran O’Riain, Sinead Toomey, Aoife Carr, Kirsten M. Timms, Sharon O’Toole, Stephen Madden, Mark Bates, John J. O’Leary, Noreen Gleeson, Dearbhaile O’Donnell, Liam Grogan, Oscar Breathnach, Angela Farrelly, Britta Stordal, Bryan T. Hennessy
-
Obstet Gynecol Sci. 2020;63(5):643-654. Published online September 2, 2020
-
-
Full text PubReader ePub Crossref - TDM PDF
-
Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
-
Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi
-
Obstet Gynecol Sci. 2019;62(6):411-419. Published online October 11, 2019
-
-
Full text PubReader Crossref - TDM PDF Supplementary Material
-
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
-
Wonkyo Shin, Hye-joo Lee, Seong J. Yang, E sun Paik, Hyun-jin Choi, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
-
Obstet Gynecol Sci. 2018;61(3):352-358. Published online May 9, 2018
-
-
Full text PubReader Crossref - TDM PDF